"Integrin beta1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Integrin beta chain expressed as a heterodimer that is non-covalently associated with specific alpha-chains of the CD49 family (CD49a-f). It is expressed on resting and activated leukocytes and is a marker for all of the very late activation antigens on cells. (from: Barclay et al., The Leukocyte Antigen FactsBook, 1993, p164)
| Descriptor ID |
D019012
|
| MeSH Number(s) |
D12.776.543.750.705.408.200.500
|
| Concept/Terms |
Integrin beta1- Integrin beta1
- CD29 Antigen
- Antigen, CD29
- CD29 Antigens
- beta1 Integrin
- Integrin, beta1
- 4B4 Antigen
- Antigen, 4B4
- CDw29 Antigen
- Antigen, CDw29
- Antigens, CD29
|
Below are MeSH descriptors whose meaning is more general than "Integrin beta1".
Below are MeSH descriptors whose meaning is more specific than "Integrin beta1".
This graph shows the total number of publications written about "Integrin beta1" by people in this website by year, and whether "Integrin beta1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 3 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Integrin beta1" by people in Profiles.
-
?1 integrins regulate cellular behaviour and cardiomyocyte organization during ventricular wall formation. Cardiovasc Res. 2024 Sep 21; 120(11):1279-1294.
-
microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin ?1 recycling on the membrane. Apoptosis. 2024 Feb; 29(1-2):191-209.
-
EZH2 engages TGF? signaling to promote breast cancer bone metastasis via integrin ?1-FAK activation. Nat Commun. 2022 05 10; 13(1):2543.
-
Dermal aSMA+ myofibroblasts orchestrate skin wound repair via ?1 integrin and independent of type I collagen production. EMBO J. 2022 04 04; 41(7):e109470.
-
Calpain-2 regulates hypoxia/HIF-induced plasticity toward amoeboid cancer cell migration and metastasis. Curr Biol. 2022 01 24; 32(2):412-427.e8.
-
Enhancing 223Ra Treatment Efficacy by Anti-?1 Integrin Targeting. J Nucl Med. 2022 07; 63(7):1039-1045.
-
P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin ?1/NF-?B pathway. Cell Cycle. 2021 09; 20(18):1875-1889.
-
UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-?/Src signaling in breast cancer cells. Mol Cell Biochem. 2021 May; 476(5):2075-2084.
-
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma. Clin Cancer Res. 2020 11 15; 26(22):6039-6050.
-
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing ?1 Integrin, Enhancing Drug Resistance. Cancer Res. 2020 08 15; 80(16):3222-3235.